MVP.AX - Medical Developments International Limited

ASX - ASX Delayed Price. Currency in AUD

Medical Developments International Limited

4 Caribbean Drive
Scoresby, VIC 3179
61 3 9547 1888

IndustryDrug Manufacturers - Major
Full Time Employees53

Key Executives

Mr. John Stewart Sharman M.App.Fin, CA, B EcChief Exec. Officer501.93kN/A51
Mr. Mark Edwards BAcc, CACFO & Company Sec.174.91kN/AN/A
Dr. Scott CourtneyDirector of Research & OperationsN/AN/AN/A
Glenn GilbertGen. Mang. of Sales & MarketingN/AN/AN/A
Maggie OhDirector of Scientific AffairsN/AN/AN/A
Amounts are as of December 31, 2017 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.


Medical Developments International Limited manufactures and distributes pharmaceutical drugs, and medical and veterinary equipment. The company operates in three segments: Pharmaceuticals, Medical Devices, and Veterinary products. It offers asthma and COPD pressurized metered dose inhalers, as well as masks and peak flow meters for asthma management; Penthrox, a prescription only medicine for acute pain; medical devices; and various veterinary anesthetic machines to veterinarians. The company operates in Australia, Europe, North America, the Middle East, Asia, and South Africa. Medical Developments International Limited is headquartered in Scoresby, Australia.

Corporate Governance

Medical Developments International Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.